Safety Planning Intervention Telehealth Service Model in Emergency Departments
Launched by UNIVERSITY OF PENNSYLVANIA · Mar 23, 2022
Trial Information
Current as of November 14, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is testing two ways to help people at risk of suicide who visit the emergency department (ED). All participants will receive Safety Planning Intervention plus follow-up contacts (SPI+), but the way SPI+ is delivered differs: in the “Enhanced Usual Care” arm, ED staff provide SPI+ and follow-up calls themselves; in the SPCC arm, ED staff refer the patient to an off-site Suicide Prevention Consultation Center (SPCC) that delivers SPI+ and follow-up calls to the patient via telehealth. The goal is to see which approach more effectively reduces suicide attempts and related hospital visits, and how well patients stay engaged with outpatient mental health care after leaving the ED.
Eligible participants are adults 18 and older who come to participating EDs for a suicide-related event or are judged at risk for suicide by ED staff, and who are not admitted to inpatient care after the ED visit. English-speaking patients who have a phone and can consent are eligible, with some additional criteria for ED clinicians or leaders who may refer patients. Participants can expect to receive SPI+ and two or more post-discharge follow-up calls, with monitoring over about six months for outcomes like suicide attempts, suicide-related ED visits or hospitalizations, and engagement in outpatient treatment. The study is led by the University of Pennsylvania and funded in part by NIMH, enrolling at multiple sites since 2022, with results expected around 2026.
Gender
ALL
Eligibility criteria
- Aim 1/Aim 3:
- Inclusion Criteria:
- • ED visit at one of our participating sites for a suicide-related event or determined to be at risk for suicide per the Electronic Health Record (EHR) and ED clinical staff
- • 18 years of age or older
- • Not admitted to an inpatient hospital following the index ED visit as documented in the EHR
- Exclusion Criteria:
- • - Inpatient admission following the index ED visit per the EHR
- Aim 2:
- Inclusion Criteria:
- • ED clinician or leader at one of our participating sites, or ED patient who was referred to the SPCC
- • 18 years of age or older
- • Able to communicate in English
- • Willing to give informed consent
- Exclusion Criteria:
- • Patients who are at imminent risk of suicide or acutely psychotic at the time of the interview, requiring emergency services and/or precluding ability to provide informed consent
- • Patients without a phone for contact
About University Of Pennsylvania
The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Gregory K Brown, PhD
Principal Investigator
University of Pennsylvania
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials